Terms ending in 2034
Every in-force patent on NuVasive, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,339,309 | Systems and Methods for Inserting Cross-Connectors In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 10,179,014 | Systems and Methods for Promoting Sacroiliac Joint Fusion In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 11,871,971 | Adjustable Devices for Treating Arthritis of the Knee In force · Medium confidence | NuVasive Specialized Orthopedics, Inc. | In force | Medium confidence | |
| US 9,655,505 | Systems and Methods for Performing Neurophysiologic Monitoring During Spine Surgery In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 11,969,162 | Systems and Methods for Performing Spine Surgery In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 9,750,508 | Insulated Pedicle Access System and Related Methods In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 10,034,695 | Spinal Alignment Frame In force · High confidence | Nuvasive,inc. | In force | High confidence | |
| US 10,716,601 | Spinal Alignment Frame In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 11,633,522 | Malleable, Cryopreserved Osteogenic Compositions with Viable Cells In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 12,185,990 | Spinal Alignment Frame In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| 64 more term ends in 2034 · Pro | |||||
10 of 74 patents shown. Soonest term end first, then patent number.
Pro members see all 74.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.